Author:
Leblanc Soline,Blein Cécile,Andremont Antoine,Bandinelli Pierre-Alain,Galvain Thibaut
Abstract
OBJECTIVETo describe the hospital stays of patients with Clostridium difficile infection (CDI) and to measure the hospitalization costs of CDI (as primary and secondary diagnoses) from the French national health insurance perspectiveDESIGNBurden of illness studySETTINGAll acute-care hospitals in FranceMETHODSData were extracted from the French national hospitalization database (PMSI) for patients covered by the national health insurance scheme in 2014. Hospitalizations were selected using the International Classification of Diseases, 10threvision (ICD-10) code for CDI. Hospital stays with CDI as the primary diagnosis or the secondary diagnosis (comorbidity) were studied for the following parameters: patient sociodemographic characteristics, mortality, length of stay (LOS), and related costs. A retrospective case-control analysis was performed on stays with CDI as the secondary diagnosis to assess the impact of CDI on the LOS and costs.RESULTSOverall, 5,834 hospital stays with CDI as the primary diagnosis were included in this study. The total national insurance costs were €30.7 million (US $33,677,439), and the mean cost per hospital stay was €5,267±€3,645 (US $5,777±$3,998). In total, 10,265 stays were reported with CDI as the secondary diagnosis. The total national insurance additional costs attributable to CDI were estimated to be €85 million (US $93,243,725), and the mean additional cost attributable to CDI per hospital stay was €8,295±€17,163, median, €4,797 (US $9,099±$8,827; median, $5,262).CONCLUSIONCDI has a high clinical and economic burden in the hospital, and it represents a major cost for national health insurance. When detected as a comorbidity, CDI was significantly associated with increased LOS and economic burden. Preventive approaches should be implemented to avoid CDIs.Infect Control Hosp Epidemiol 2017;38:906–911
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference35 articles.
1. French guidelines for the economic evaluation of health care technologies. Collège des Economites de la Santé website. http://www.ces-asso.org/docs/France_Guidelines_HE_Evaluation.pdf. Published 2004. Accessed October 28, 2016.
2. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals
3. Epidemiology of pulmonary tuberculosis in France. Can the hospital discharge database be a reliable source of information?
4. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals: 2011–2012. European Center for Disease Prevention and Control website. http://ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf. Published 2013. Accessed May 11, 2017.
5. Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献